LadRx Corp
LADXHealthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$3.6M | −$3.8M | −$4.6M | −$12.1M | −$6.8M | −$7.9M |
| Net income | −$1.6M | $400,443 | −$4.2M | −$13.2M | −$6.7M | −$7.2M |
| Total assets | $839,512 | $2.3M | $2.2M | $8.7M | $12.1M | $17.3M |
| Total liabilities | — | $2.2M | $2.2M | $4.0M | $3.2M | $2.1M |
| Equity | −$1.4M | $107,354 | −$1.3M | $753,719 | $8.9M | $15.2M |
| EPS (diluted) | $-3.21 | $0.68 | $-0.11 | $-0.35 | — | — |
| Shares out. | 495,092 | 46.6M | 38.8M | 36.5M | 33.6M | 33.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- —
- Net margin
- —
- Return on equity
- 112.0%
- Return on assets
- −189.4%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-2.87
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −497.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Accruals / assets
- −33.3%clean
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 13, 2008
- NT 10-Kmissed a reporting deadline ↗Mar 18, 2008
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2007
- NT 10-Kmissed a reporting deadline ↗Mar 19, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2006
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 180 | 3.9 | 0.0% |
| Apr 30, 2026 | 180 | 2.5 | 0.0% |
| Apr 15, 2026 | 180 | 1.0 | 0.0% |
| Mar 31, 2026 | 180 | 9.5 | 0.0% |
| Mar 13, 2026 | 180 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Debt acceleration / triggering event · Director / officer changeJul 31, 2025
- Other material eventJun 27, 2025
- Director / officer changeApr 16, 2025
- Shareholder voteOct 9, 2024
- Entered a material agreement · Terminated a material agreement · Other material eventJun 6, 2024
- Modified shareholder rights · Director / officer change · Amended charter or bylaws · Shareholder voteSep 11, 2023
- Entered a material agreement · Completed an acquisition or disposition · Other material eventJun 26, 2023
- Modified shareholder rights · Amended charter or bylaws · Regulation FD disclosureMay 11, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.